Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
cd19 car-t cells (4 trials)
cyclophosphamide (cytoxan) (2 trials)
fludarabine (fludara) (2 trials)
Multiple Myeloma (Phase 1)
Neoplasms, Plasma Cell (Phase 1)
Precursor Cell Lymphoblastic Leukemia-Lymphoma (Phase 1)
Trials (5 total)
Trial APIs (3 total)